Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Urinary Bladder Neoplasms 2Urinary Tract Infections 1Tissue Adhesions 1Polyps 1Non-Muscle Invasive Bladder Neoplasms 1Neutropenia 1Neoplasms 1Myoma 1Multiple Myeloma 1Infections 1Hematologic Neoplasms 1Hearing Loss 1Febrile Neutropenia 1Endometritis 1Ear Neoplasms 1Cystitis 1

Interventions

Meropenem 7Vancomycin 6Filgrastim 5Ceftazidime 5pegylated granulocyte colony-stimulating factor 4Cefepime 4pegfilgrastim 3Levofloxacin 3Ciprofloxacin 3Amikacin 3Teicoplanin 2Piperacillin, Tazobactam Drug Combination 2Linezolid 2Interleukin 1 Receptor Antagonist Protein 2Amoxicillin-Potassium Clavulanate Combination 2ceftolozane, tazobactam drug combination 1Vaccination 1Therapeutics 1Tazobactam 1TKN732 1Sodium Chloride 1Simvastatin 1Positron Emission Tomography Computed Tomography 1Pneumococcal Vaccines 1Piperacillin 1Ofloxacin 1NF protocol 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Micafungin 1Metronidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Febrile Neutropenia × Ofloxacin × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡